Partial Replicated Crossover Clinical Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203 Treatment to Those of Co-administration of Eperisone Hydrochloride Slow Release and Aceclofenac in Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Aceclofenac/eperisone (Primary) ; Aceclofenac; Eperisone
- Indications Back pain
- Focus Pharmacokinetics
- Sponsors Navipharm
- 24 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 24 Mar 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 24 Mar 2016 Status changed from not yet recruiting to suspended due to operational reasons as reported by ClinicalTrials.gov.